Mirae Asset Global Investments
LGND icon

Mirae Asset Global Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Mirae Asset Global Investments’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Sell
896
-144
-14% -$33.9K ﹤0.01% 1069
2026
Q1 		$208K Buy
1,040
+84
+9% +$16.6K ﹤0.01% 1064
2025
Q4 		$181K Buy
956
+198
+26% +$38K ﹤0.01% 1158
2025
Q3 		$134K Buy
758
+13
+2% +$1.93K ﹤0.01% 1169
2025
Q2 		$84.7K Buy
745
+92
+14% +$9.83K ﹤0.01% 1166
2025
Q1 		$70.3K Buy
653
+23
+4% +$2.6K ﹤0.01% 1178
2024
Q4 		$68.8K Sell
630
-31
-5% -$3.5K ﹤0.01% 1210
2024
Q3 		$64.4K Buy
661
+125
+23% +$12.6K ﹤0.01% 1253
2024
Q2 		$44.1K Buy
+536
New +$42.7K ﹤0.01% 1273

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Mirae Asset Global Investments's LGND Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Ligand Pharmaceuticals (LGND) stake by 14% in Q2 2026, selling an estimated $33.9K and leaving 896 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

Mirae Asset Global Investments first reported a position in LGND in Q2 2024 and has held it in 9 quarters since. 199 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Mirae Asset Global Investments held 896 shares of Ligand Pharmaceuticals worth $283K as of Q2 2026.
  • Mirae Asset Global Investments sold 144 Ligand Pharmaceuticals shares in Q2 2026, an estimated $33.9K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1069 holding.
  • Mirae Asset Global Investments first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 199 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.